Journal of Antimicrobial Chemotherapy, Vol 41, 403-405, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
MA Shapiro, JC Sesnie, TM Desaty, TJ Griffin and CL Heifetz
A deep-seated Pseudomonas aeruginosa mouse kidney abscess model was used to
compare the therapeutic efficacy of clinafloxacin, a fluoroquinolone in
clinical trials, with that of clinically relevant standard drugs. Following
50 mg/kg oral doses, twice daily for five consecutive days, clinafloxacin
produced a 4 log decrease in mean bacterial count, the greatest decrease of
all drugs tested. The same dosage regimen resulted in complete bacterial
eradication in 88% of the kidneys. No other compound produced total
bacterial clearance in 50% of the kidneys at the highest dose tested.
ORIGINAL ARTICLES
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model
Department of Infectious Diseases, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?